Literature DB >> 16896018

Doxycycline for community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.

Melinda K Carter, Vernessa A Ebers, Bachir K Younes, Melinda K Lacy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16896018     DOI： 10.1345/aph.1H084

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  2 in total

1.  Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus.

Authors:  Mary Jo Cenizal; Daniel Skiest; Samuel Luber; Roger Bedimo; Pat Davis; Patrick Fox; Kathleen Delaney; R Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

2.  Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Jörg J Ruhe; Anupama Menon
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.